Analytics

Dr. John B. Halamka, president of Mayo Clinic Platform, discusses AI's "dizzying" evolution, Mayo’s strategy for approaching predictive AI versus generative AI, and its partnership with Google that practices agile development of AI.

Dr. Brian Anderson, MITRE’s chief digital health physician and Coalition for Health AI cofounder, says AI requires regulation. He discusses the blueprint CHI developed for bias-mitigation, transparency, governance and monitoring in AI.

Niall O'Connor, chief technology officer at Cohere Health, discusses how AI and machine learning can help streamline the prior authorization process by analyzing the totality of patient information and reducing denials by health plans.

Dr. Oscar Marroquin, chief healthcare data and analytics officer at UPMC, discusses clinical analytics' relationship with artificial intelligence, and the importance of understanding the foundational elements of using AI in healthcare.

Also, AIM will be collaborating with Stanford Medicine to validate its diagnostic endoscopic AI.

HIMSS23 attendees discuss the conference post-pandemic, how attending helps explore new pathways for their company, and what technologies they look forward to learning about most on the exhibit floor.

Edward Yurcisin, chief technology officer at NCQA, tells how health plans and organizations can improve healthcare quality by utilizing open-source innovation between payers and providers and how NCQA works to help them achieve that goal.

It uses a competitive learning approach against unlabelled data. 

Freddie Feldman, director of voice and conversational interfaces at Wolters Kluwer, talks about the potential of using AI and natural language processing for voice interfaces, and about limitations in the answers that generative AI can provide.

Dr. Payel Das, principal research staff member and manager in the Trusted AI department of IBM, and an IBM master inventor, relays how using large language models that fill gaps in datasets may improve drug discovery in the future.